Provided by Tiger Trade Technology Pte. Ltd.

Corbus Pharmaceuticals

8.12
+0.02000.25%
Post-market: 8.02-0.1000-1.23%19:31 EST
Volume:457.27K
Turnover:3.71M
Market Cap:142.53M
PE:-1.47
High:8.32
Open:8.15
Low:7.97
Close:8.10
52wk High:20.56
52wk Low:4.64
Shares:17.55M
Float Shares:12.29M
Volume Ratio:1.29
T/O Rate:3.72%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.5180
EPS(LYR):-3.6837
ROE:-55.65%
ROA:-34.69%
PB:1.55
PE(LYR):-2.20

Loading ...

Company Profile

Company Name:
Corbus Pharmaceuticals
Exchange:
NASDAQ
Establishment Date:
2009
Employees:
28
Office Location:
500 River Ridge Drive,Norwood,Massachusetts,United States
Zip Code:
02062
Fax:
617 663 6085
Introduction:
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, develops products to defeat serious illness. It develops CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E (MMAE), which is in Phase I clinical trial; CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells for the treatment of solid tumors; CRB-913, a peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. It has a licensing agreement with Jenrin Discovery, LLC to develop and commercialize the licensed products, including the Jenrin library of approximately 600 compounds, and multiple issued and pending patent filings. The company was incorporated in 2009 and is based in Norwood, Massachusetts.

Directors

Name
Position
Yuval Cohen
Chief Executive Officer and Director
Anne Altmeyer
Independent Director
John Jenkins
Independent Director
Rachelle Jacques
Independent Director
Winston Kung
Independent Director
Yong Ben
Independent Director

Shareholders

Name
Position
Yuval Cohen
Chief Executive Officer and Director
Ian Hodgson
Chief Operating Officer
Sean Moran
Chief Financial Officer
Dominic Smethurst
Chief Medical Officer